Scotia Capital’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $99.6K | Buy |
29,024
+12,953
| +81% | +$44.4K | ﹤0.01% | 831 |
|
|
2025
Q1 | $35.8K | Buy |
16,071
+947
| +6% | +$2.11K | ﹤0.01% | 829 |
|
|
2024
Q4 | $44.3K | Hold |
15,124
| – | – | ﹤0.01% | 834 |
|
|
2024
Q3 | $39.3K | Buy |
15,124
+55
| +0.4% | +$143 | ﹤0.01% | 819 |
|
|
2024
Q2 | $44.6K | Hold |
15,069
| – | – | ﹤0.01% | 810 |
|
|
2024
Q1 | $68.3K | Buy |
+15,069
| New | +$68.3K | ﹤0.01% | 801 |
|
|
2022
Q1 | – | Sell |
-13,127
| Closed | -$188K | – | 872 |
|
|
2021
Q4 | $188K | Sell |
13,127
-2,896
| -18% | -$41.5K | ﹤0.01% | 812 |
|
|
2021
Q3 | $321K | Buy |
16,023
+1,757
| +12% | +$35.2K | ﹤0.01% | 694 |
|
|
2021
Q2 | $314K | Buy |
+14,266
| New | +$314K | ﹤0.01% | 702 |
|